(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 130.04% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Invivyd's revenue in 2025 is $25,384,000.On average, 2 Wall Street analysts forecast IVVD's revenue for 2025 to be $20,651,362,757, with the lowest IVVD revenue forecast at $13,435,681,840, and the highest IVVD revenue forecast at $27,867,043,674. On average, 2 Wall Street analysts forecast IVVD's revenue for 2026 to be $26,283,552,600, with the lowest IVVD revenue forecast at $22,792,674,550, and the highest IVVD revenue forecast at $29,774,430,649.
In 2027, IVVD is forecast to generate $39,131,423,359 in revenue, with the lowest revenue forecast at $39,131,423,359 and the highest revenue forecast at $39,131,423,359.